1. Home
  2. VATE vs ONCY Comparison

VATE vs ONCY Comparison

Compare VATE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.54

Market Cap

70.3M

Sector

Industrials

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.02

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VATE
ONCY
Founded
1994
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.3M
106.1M
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
VATE
ONCY
Price
$4.54
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.00
AVG Volume (30 Days)
16.3K
695.5K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,099,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.05
$0.33
52 Week High
$13.79
$1.51

Technical Indicators

Market Signals
Indicator
VATE
ONCY
Relative Strength Index (RSI) 32.98 46.86
Support Level $4.76 $0.94
Resistance Level $5.28 $1.01
Average True Range (ATR) 0.24 0.06
MACD -0.07 0.01
Stochastic Oscillator 24.99 69.83

Price Performance

Historical Comparison
VATE
ONCY

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: